Marc Riedl
UC San Diego, La Jolla, California, United States · UCSD · University of California, Los Angeles
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Marc Riedl as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:22 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05047185 · Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type IIPharvaris Netherlands B.V. · terminated · Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II · principal investigator
- Ph2/Ph3NCT02303626 · 12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE AttacksBioCryst Pharmaceuticals · completed · Hereditary Angioedema, HAE · principal investigator
- N/ANCT00915447 · Diesel Exhaust Particles and Leukotriene ProductionUniversity of California, Los Angeles · withdrawn · Allergic Rhinitis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- THE ROLE OF GENES IN DETERMINING THE EFFECT OF DIESEL PARTICLES ON ALLERGIC RESPM01RR000865 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · fiscal years 2006 to 2009 · $3,879 awarded in 2009Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:22 UTC. The ranking covers the 200 most relevant of 80 PubMed records, and a shared surname and initials can bring in a namesake. All 80 on PubMed
- Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.N Engl J Med · 2010447 citationsRCR 13.8
- 253 citationsRCR 10.8
- Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.Ann Allergy Asthma Immunol · 2011193 citationsRCR 6.2
- 173 citationsRCR 7.7
- Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial.Lancet Diabetes Endocrinol · 2018173 citationsRCR 8.9
- Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway.Clin Immunol · 2009170 citationsRCR 5.0
- Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis.N Engl J Med · 2017139 citationsRCR 5.1
- Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial.J Allergy Clin Immunol · 2021138 citationsRCR 11.7
- Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men.Am J Physiol Endocrinol Metab · 2008134 citationsRCR 3.9
- Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study.Allergy · 202287 citationsRCR 9.5